No annual revenue total was found in BEACON TOPCO, INC.'s SEC filings.
Beacon Topco, Inc. (CLYD) files with the SEC under industry code 2834, Pharmaceutical Preparations.
Revenue
—
Net income
—
Operating cash flow
—
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
—
Net cash
—
Operating margin
—
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CLYD
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Germantown, MD
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2094256
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement, Other events
|
Sep 24, 2026 | Sep 22, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Sep 17, 2026 | Sep 15, 2026 |
| 10-Q | Quarterly report | Jul 14, 2026 | Jun 30, 2026 |
| 10-Q | Quarterly report | Jun 5, 2026 | Mar 31, 2026 |
All 17 Beacon Topco, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.